Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

Celgene Fined $280 Million

Celgene will pay $280 million to the United States, 28 states and the District of Columbia to settle claims it promoted cancer drugs Thalomid and Revlimid for unapproved uses and submitted fraudulent Medicare and Medi-Cal claims for it, federal prosecutors said Tuesday.

LOS ANGELES — Celgene will pay $280 million to the United States, 28 states and the District of Columbia to settle claims it promoted cancer drugs Thalomid and Revlimid for unapproved uses and submitted fraudulent Medicare and Medi-Cal claims for it, federal prosecutors said Tuesday.

Categories / Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...